Tallink Grupp
AS Tallink Grupp Investor Webinar introducing the results of the Q2 of 2025
AS Tallink Grupp Investor Webinar introducing the results of the Q2 of 2025
AS Tallink Grupp will introduce the results of the second quarter of 2025 in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 24 July 2025 at 12:00 (EEST). The webinar will be held in English.
The financial results will be presented by the Chairman of the Management Board Paavo Nõgene and the members of the Management Board Harri Hanschmidt and Margus Schults.
We kindly ask participants to provide their questions before the webinar, latest by
11:00 am on 24 July 2025, by e-mail to: investor@tallink.ee. Due to time constraint, preference will be given to questions submitted in writing before the webinar.
How to join the webinar?
The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. To participate, please join the webinar on 24 July 2025 at 12:00 (EEST) via the following link.
As there is no prior registration needed and no reminder of the webinar will be sent, we recommend that all interested parties mark their calendar with the webinar info.
You can either participate by joining from your web browser or via Microsoft Teams application. When using a smart device to join the webinar, you first need to download the Microsoft Teams application from either Play Store or App Store.
The webinar will be recorded and will be available online for everyone on the company’s website at Reports & Financial key figures.
Anneli Simm
Investor Relations Manager
AS Tallink Grupp
Sadama 5
10111 Tallinn, Estonia
E-mail: anneli.simm@tallink.ee
Phone: +372 56157170
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
SpringWorks Therapeutics, Inc.18.7.2025 17:30:40 CEST | Press release
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photocat A/S18.7.2025 17:00:00 CEST | Press release
PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market.
Golden Ocean Group Limited18.7.2025 16:30:00 CEST | Press release
GOGL – Notice of Special General Meeting
Kapitalforeningen SDG Invest18.7.2025 16:06:31 CEST | Pressemeddelelse
Kapitalforeningen SDG Invest - Opdateret prospekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom